North America Rna Targeting Small Molecule Drug Discovery Market Size & Outlook
- HC Outsourcing
- CRO
- RNA Targeting Small Molecule Drug Discovery Market Outlook
- CRO
North America Rna Targeting Small Molecule Drug Discovery Market, 2018-2030 (US$M)
Global Market
Related Markets
Ask Prism AI about the rna targeting small molecule drug discovery market
Get cited answers from GVR research on market growth, segments, regulations and forecasts.
- Source-linked answers
- Market-specific context
- Traceable figures
North America rna targeting small molecule drug discovery market highlights
- The North America rna targeting small molecule drug discovery market generated a revenue of USD 1,006.0 million in 2024.
- The market is expected to grow at a CAGR of 22% from 2025 to 2030.
- In terms of segment, neurological diseases was the largest revenue generating indication in 2024.
- Cancer is the most lucrative indication segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2025 to 2030.
North America data book summary
| Market revenue in 2024 | USD 1,006.0 million |
| Market revenue in 2030 | USD 3,306.3 million |
| Growth rate | 22% (CAGR from 2025 to 2030) |
| Largest segment | Neurological diseases |
| Fastest growing segment | Cancer |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cancer, Infectious Diseases, Metabolic Diseases, Neurological Diseases |
Other key industry trends
- In terms of revenue, North America region accounted for 60.7% of the global rna targeting small molecule drug discovery market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- North America is the fastest growing regional market and is projected to reach USD 3,306.3 million by 2030.
No credit card required*
Publish Date: Feb 20, 2025
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
RNA Targeting Small Molecule Drug Discovery Market Scope
RNA Targeting Small Molecule Drug Discovery Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
North America RNA Targeting Small Molecule Drug Discovery Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to RNA Targeting Small Molecule Drug Discovery Market Outlook will help companies and investors design strategic landscapes.
Neurological Diseases was the largest segment with a revenue share of 49.17% in 2024.
Horizon Databook has segmented the North America rna targeting small molecule drug discovery market based on cancer, infectious diseases, metabolic diseases, neurological diseases covering the revenue growth of each sub-segment from 2018 to 2030.
- North America Rna Targeting Small Molecule Drug Discovery Market Indication Outlook (Revenue, USD Million , 2018-2030)
- Cancer
- Infectious Diseases
- Metabolic Diseases
- Neurological Diseases
- Others
- North America Rna Targeting Small Molecule Drug Discovery Market End Use Outlook (Revenue, USD Million , 2018-2030)
- Pharmaceutical and Biopharmaceutical Companies
- Academic and Research Institutes
- Others
Reasons to subscribe to RNA Targeting Small Molecule Drug Discovery Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of RNA Targeting Small Molecule Drug Discovery Market Outlook databook
- Our clientele includes a mix of RNA Targeting Small Molecule Drug Discovery Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America RNA Targeting Small Molecule Drug Discovery Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into North America RNA Targeting Small Molecule Drug Discovery Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
North America Rna Targeting Small Molecule Drug Discovery Market, 2018-2030 (US$M)
North America rna targeting small molecule drug discovery market statistics, by indication, 2018-2030 (US$M)
